1-Cyclopentanecarbonylazetidine-3-sulfonyl chloride

Catalog No. :
ACOCXH652
CAS No. :
1461715-32-1
Molecular Formula :
C9H14ClNO3S
Molecular Weight :
251.74

IUPAC Name:1-(cyclopentanecarbonyl)azetidine-3-sulfonyl chloride

1-Cyclopentanecarbonylazetidine-3-sulfonyl chloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$169.00Login to see priceInquiryInquiry
100mg98%$244.00Login to see priceInquiryInquiry
250mg98%$341.00Login to see priceInquiryInquiry
1g98%$672.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Cyclopentanecarbonylazetidine-3-sulfonyl chloride
IUPAC Name1-(cyclopentanecarbonyl)azetidine-3-sulfonyl chloride
MDL No.MFCD26407571
Molecular FormulaC9H14ClNO3S
Molecular Weight251.74
SMILESO=S(C1CN(C(C2CCCC2)=O)C1)(Cl)=O
InChI KeyYQHUVWISAHUGSF-UHFFFAOYSA-N
Synonym1-cyclopentanecarbonylazetidine-3-sulfonyl chloride;3-Azetidinesulfonyl chloride, 1-(cyclopentylcarbonyl)-
CAS No.1461715-32-1

Safety Data

Pictogram
Harmful or irritantCorrosive
Signal Word
Gefahr
Hazard Statement(s)
H314-H335
Precautionary Statement(s)
P260-P264-P271-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACOCXH652 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQCVY160 route compound structure diagram
    ACQCVY1603400-45-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOCXH652 route product structure diagram
    ACOCXH6521461715-32-1
Inquiry

2. ACOCXH652 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWGDT861 route compound structure diagram
    ACWGDT8614524-93-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOCXH652 route product structure diagram
    ACOCXH6521461715-32-1
Inquiry

Comments (0)